|
|
||||||||
Correspondence to:
Ronald P. Mensink.
Studying the effects of dietary fish oil on VLDL metabolism in humans is subject to both large intra- and interindividual variability. In the present study we therefore used hyperlipidemic apolipoprotein (APO) E*3-Leiden mice, which have impaired chylomicron and very low density lipoprotein (VLDL) remnant metabolism, to study the effects of dietary fish oil on serum lipids and VLDL kinetics under highly standardized conditions. For this, female APOE*3-Leiden mice were fed a fat- and cholesterol-containing diet supplemented with either 0, 3 or 6% w/w (i.e. 0, 6, or 12% of total energy) of fish oil. Fish oil-fed mice showed a significant dose-dependent decrease in serum cholesterol (up to -43%) and triglyceride levels (up to -60%), mainly due to a reduction of VLDL (-80%). LDL and HDL cholesterol levels were not affected by fish oil feeding. VLDL-apoB kinetic studies showed that fish oil feeding resulted in a significant 2-fold increase in VLDL-apoB fractional catabolic rate (FCR). Hepatic VLDL-apoB production was, however, not affected by fish oil feeding. VLDL-triglyceride turnover studies revealed that fish oil significantly decreased hepatic VLDL-triglyceride production rate (-60%). A significant increase in VLDL-triglyceride FCR was observed (+70%), which was not related to increased lipolytic activity.
We conclude that APOE*3-Leiden mice are highly responsive to dietary fish oil. The observed strong reduction in serum very low density lipoprotein (VLDL) is primarily due to an effect of fish oil to decrease hepatic VLDL triglyceride production rate and to increase VLDL-apoB fractional catabolic rate.van Vlijmen, B. J. M., R. P. Mensink, H. B. van 't Hof, R. F. G. Offermans, M. H. Hofker, and L. M. Havekes. Effects of dietary fish oil on serm lipids and VLDL kinetics in hyperlipidemic apolipoprotein E*3-Leiden transgenic mice. J. Lipid Res. 1998. 39: 11811188.
Supplementary key words:
dietary fish oil, n3 fatty acids, VLDL metabolism, hyperlipidemia, transgenic mice
Copyright © 1998 by Lipid Research, Inc.
Original Article
Effects of dietary fish oil on serum lipids and VLDL kinetics in hyperlipidemic apolipoprotein E*3-Leiden transgenic mice
Bart J. M. van Vlijmena,
Ronald P. Mensinkb,
H. Belinda van 't Hofa,
Rene F. G. Offermansb,
Marten H. Hofkerc, and
Louis M. Havekesa,d
a TNO Prevention and Health, Gaubius Laboratory, Leiden
b Department of Human Biology, Maastricht University, Maastricht
c MGC-Department of Human Genetics, Leiden University, Leiden, and Departments of Cardiology and Internal Medicine,
d MGC-Department of Human Genetics, Academic Hospital Leiden, Leiden, The Netherlands
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
C. C. van der Hoogt, W. de Haan, M. Westerterp, M. Hoekstra, G. M. Dallinga-Thie, J. A. Romijn, H. M. G. Princen, J. W. Jukema, L. M. Havekes, and P. C. N. Rensen Fenofibrate increases HDL-cholesterol by reducing cholesteryl ester transfer protein expression J. Lipid Res., August 1, 2007; 48(8): 1763 - 1771. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-L. Ricketts, M. V. Boekschoten, A. J. Kreeft, G. J. E. J. Hooiveld, C. J. A. Moen, M. Muller, R. R. Frants, S. Kasanmoentalib, S. M. Post, H. M. G. Princen, et al. The Cholesterol-Raising Factor from Coffee Beans, Cafestol, as an Agonist Ligand for the Farnesoid and Pregnane X Receptors Mol. Endocrinol., July 1, 2007; 21(7): 1603 - 1616. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. S. Espirito Santo, B. J. M. van Vlijmen, R. Buytenhek, W. van Duyvenvoorde, L. M. Havekes, I. Arnault, J. Auger, and H. M. G. Princen Well-Characterized Garlic-Derived Materials Are Not Hypolipidemic in APOE*3-Leiden Transgenic Mice J. Nutr., June 1, 2004; 134(6): 1500 - 1503. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Muurling, R. P. Mensink, H. Pijl, J. A. Romijn, L. M. Havekes, and P. J. Voshol A Fish Oil Diet Does Not Reverse Insulin Resistance despite Decreased Adipose Tissue TNF-{alpha} Protein Concentration in ApoE-3*Leiden Mice J. Nutr., November 1, 2003; 133(11): 3350 - 3355. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. L. Volger, H. van der Boom, E. C. M. de Wit, W. van Duyvenvoorde, G. Hornstra, J. Plat, L. M. Havekes, R. P. Mensink, and H. M. G. Princen Dietary Plant Stanol Esters Reduce VLDL Cholesterol Secretion and Bile Saturation in Apolipoprotein E*3-Leiden Transgenic Mice Arterioscler. Thromb. Vasc. Biol., June 1, 2001; 21(6): 1046 - 1052. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. M. Delsing, E. H. Offerman, W. van Duyvenvoorde, H. van der Boom, E. C. M. de Wit, M. J. J. Gijbels, A. van der Laarse, J. W. Jukema, L. M. Havekes, and H. M. G. Princen Acyl-CoA:Cholesterol Acyltransferase Inhibitor Avasimibe Reduces Atherosclerosis in Addition to Its Cholesterol-Lowering Effect in ApoE*3-Leiden Mice Circulation, April 3, 2001; 103(13): 1778 - 1786. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-C. Hsu, Y.-T. Lee, and M.-F. Chen Effect of n-3 fatty acids on the composition and binding properties of lipoproteins in hypertriglyceridemic patients1 Am. J. Clinical Nutrition, January 1, 2000; 71(1): 28 - 35. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |